GLOBAL BIO-CHEM announces interim results, with a net loss attributable to owners of approximately HKD 158 million, a year-on-year increase of 1.43 times

GLOBAL BIO-CHEM announced its mid-term performance for 2024, with revenue of approximately HKD 898.5 million, a year-on-year increase of 91.7%. However, the company's owners' share of losses amounted to approximately HKD 158 million, a 1.43-fold increase year-on-year, resulting in a loss per share of 1.8 HK cents. The revenue growth mainly stemmed from the increase in production capacity of the amino acid business and the launch of high value-added products, while the expanded losses were due to the absence of income from the termination of the recognition of Harbin Global Bio-Chem during the same period